Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albina Nowak

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Praxis|July 3, 2015
[CME. Fabry disease: rare but not to be missed]Carolin Steinack, Ariana Gaspert, Ronald Kovacs, et al.
Medicine|October 19, 2018
Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort: A prospective longitudinal observational studyAlbina Nowak, Rebekka S Giger, Pierre-Alexandre Krayenbuehl
International Journal of Cardiology|March 17, 2018
Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-upAlbina Nowak, Martin Siegenthaler, Mehdi Namdar, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Gaucher's disease - an overview about a sphingolipidosis]Raphaël Tamò, Michel Hochuli, Felix Beuschlein, et al.
Molecular Genetics and Metabolism|August 19, 2024
Clinical outcomes in elderly patients receiving agalsidase alfa treatment in the Fabry Outcome SurveyAlbina Nowak, Jaco Botha, Christina Anagnostopoulou, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Fabry disease - the profile of an orphan disease]Raphaël Tamò, Sandrine A Zweifel, Felix Beuschlein, et al.
Retina (Philadelphia, Pa.)|March 15, 2017
ASSESSMENT OF DRUSEN AND OTHER RETINAL DEGENERATIVE CHANGES IN PATIENTS WITH HEREDITARY HEMOCHROMATOSISMoreno Menghini, Christian Prünte, Pierre A Krayenbuehl, et al.
Praxis|May 12, 2016
[Approach to the Patient with Elevated Serum Ferritin]Florentine Schreiner, Pierre-Alexandre Krayenbühl, Jeroen Goede, et al.
Journal of Clinical Laboratory Analysis|September 20, 2017
Evaluation of the new restandardized Abbott Architect 25-OH Vitamin D assay in vitamin D-insufficient and vitamin D-supplemented individualsWijtske Annema, Albina Nowak, Arnold von Eckardstein, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[The basics of lysosomal storage diseases]Raphaël Tamò, Marianne Rohrbach, Matthias Baumgartner, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Praxis|July 3, 2015
[CME. Fabry disease: rare but not to be missed]Carolin Steinack, Ariana Gaspert, Ronald Kovacs, et al.
Medicine|October 19, 2018
Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort: A prospective longitudinal observational studyAlbina Nowak, Rebekka S Giger, Pierre-Alexandre Krayenbuehl
International Journal of Cardiology|March 17, 2018
Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-upAlbina Nowak, Martin Siegenthaler, Mehdi Namdar, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Gaucher's disease - an overview about a sphingolipidosis]Raphaël Tamò, Michel Hochuli, Felix Beuschlein, et al.
Molecular Genetics and Metabolism|August 19, 2024
Clinical outcomes in elderly patients receiving agalsidase alfa treatment in the Fabry Outcome SurveyAlbina Nowak, Jaco Botha, Christina Anagnostopoulou, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Fabry disease - the profile of an orphan disease]Raphaël Tamò, Sandrine A Zweifel, Felix Beuschlein, et al.
Retina (Philadelphia, Pa.)|March 15, 2017
ASSESSMENT OF DRUSEN AND OTHER RETINAL DEGENERATIVE CHANGES IN PATIENTS WITH HEREDITARY HEMOCHROMATOSISMoreno Menghini, Christian Prünte, Pierre A Krayenbuehl, et al.
Praxis|May 12, 2016
[Approach to the Patient with Elevated Serum Ferritin]Florentine Schreiner, Pierre-Alexandre Krayenbühl, Jeroen Goede, et al.
Journal of Clinical Laboratory Analysis|September 20, 2017
Evaluation of the new restandardized Abbott Architect 25-OH Vitamin D assay in vitamin D-insufficient and vitamin D-supplemented individualsWijtske Annema, Albina Nowak, Arnold von Eckardstein, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[The basics of lysosomal storage diseases]Raphaël Tamò, Marianne Rohrbach, Matthias Baumgartner, et al.
Pageof 11